Cargando…

Less but better: cardioprotective lipid profile of patients with GCK-MODY despite lower HDL cholesterol level

Patients with diabetes caused by single-gene mutations generally exhibit an altered course of diabetes. Those with mutations of the glucokinase gene (GCK-MODY) show good metabolic control and low risk of cardiovascular complications despite paradoxically lowered high-density lipoprotein (HDL) choles...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fendler, Wojciech, Rizzo, Manfredi, Borowiec, Maciej, Malachowska, Beata, Antosik, Karolina, Szadkowska, Agnieszka, Banach, Maciej, Urbanska-Kosinska, Malgorzata, Szopa, Magdalena, Malecki, Maciej, Mlynarski, Wojciech
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127439/ https://www.ncbi.nlm.nih.gov/pubmed/24549415 http://dx.doi.org/10.1007/s00592-014-0567-1

Ejemplares similares

Single patient in GCK-MODY family successfully re-diagnosed into GCK-PNDM through targeted next-generation sequencing technology
por: Antosik, Karolina, et al.
Publicado: (2015)

Circulating ghrelin level is higher in HNF1A–MODY and GCK–MODY than in polygenic forms of diabetes mellitus
por: Nowak, Natalia, et al.
Publicado: (2015)

A cross‐sectional study of patients referred for HNF1B‐MODY genetic testing due to cystic kidneys and diabetes
por: Sztromwasser, Paweł, et al.
Publicado: (2020)

Phenotype variability and neonatal diabetes in a large family with heterozygous mutation of the glucokinase gene
por: Borowiec, Maciej, et al.
Publicado: (2011)

Central Nervous System PET-CT Imaging Reveals Regional Impairments in Pediatric Patients with Wolfram Syndrome
por: Zmyslowska, Agnieszka, et al.
Publicado: (2014)

Differential regulation of serum microRNA expression by HNF1β and HNF1α transcription factors
por: Fendler, Wojciech, et al.
Publicado: (2016)

Abnormal serum microRNA profiles in tuberous sclerosis are normalized during treatment with everolimus: possible clinical implications
por: Trelinska, Joanna, et al.
Publicado: (2016)

GCK exonic mutations induce abnormal biochemical activities and result in GCK-MODY
por: Dai, Tongtong, et al.
Publicado: (2023)

Multi-Timepoint Metabolic Fingerprinting of a Post-Episode Period of Hypoglycemia and Ketoacidosis Among Children With Type 1 Diabetes
por: Małachowska, Beata, et al.
Publicado: (2022)

Comparison of Glomerular Filtration Rate Estimation from Serum Creatinine and Cystatin C in HNF1A-MODY and Other Types of Diabetes
por: Szopa, Magdalena, et al.
Publicado: (2015)

Next-Generation Sequencing in the Diagnosis of Patients with Bardet–Biedl Syndrome—New Variants and Relationship with Hyperglycemia and Insulin Resistance
por: Jeziorny, Krzysztof, et al.
Publicado: (2020)

Altered Platelets’ morphological parameters in children with type 1 diabetes – a case-control study
por: Malachowska, Beata, et al.
Publicado: (2015)

One-step nucleic acid amplification testing in medullary thyroid cancer lymph nodes: a case series
por: Kaczka, Krzysztof, et al.
Publicado: (2015)

Retinal thickness as a marker of disease progression in longitudinal observation of patients with Wolfram syndrome
por: Zmyslowska, Agnieszka, et al.
Publicado: (2017)

Elevated level of lysophosphatidic acid among patients with HNF1B mutations and its role in RCAD syndrome: a multiomic study
por: Małachowska, Beata, et al.
Publicado: (2022)

Cystatin C is not a good candidate biomarker for HNF1A-MODY
por: Nowak, Natalia, et al.
Publicado: (2012)

Association of circulating miRNAS in patients with Alstrőm and Bardet-Biedl syndromes with clinical course parameters
por: Zmyslowska, Agnieszka, et al.
Publicado: (2022)

MODY2 in Asia: analysis of GCK mutations and clinical characteristics
por: Zhou, Yuan, et al.
Publicado: (2020)

GCK-MODY (MODY 2) Caused by a Novel p.Phe330Ser Mutation
por: Bonfig, Walter, et al.
Publicado: (2011)

Switching to Sulphonylureas in Children With iDEND Syndrome Caused by KCNJ11 Mutations Results in Improved Cerebellar Perfusion
por: Fendler, Wojciech, et al.
Publicado: (2013)

Serum microRNA as indicators of Wolfram syndrome’s progression in neuroimaging studies
por: Zmyslowska, Agnieszka, et al.
Publicado: (2020)

Glucokinase (GCK) Mutations and Their Characterization in MODY2 Children of Southern Italy
por: Capuano, Marina, et al.
Publicado: (2012)

Clinical Heterogeneity in Monogenic Diabetes Caused by Mutations in the Glucokinase Gene (GCK-MODY)
por: Cuesta-Muñoz, Antonio L., et al.
Publicado: (2010)

Indentification of single base mutations in the GCK gene of patients with diagnosis of MODY2
por: da Rocha Carvalho Neto, Francisco Geraldo Mello, et al.
Publicado: (2015)

Phenotype Heterogeneity in Glucokinase–Maturity-Onset Diabetes of the Young (GCK-MODY) Patients
por: Wędrychowicz, Anna, et al.
Publicado: (2017)

“Pesto” Mutation: Phenotypic and Genotypic Characteristics of Eight GCK/MODY Ligurian Patients
por: Salina, Alessandro, et al.
Publicado: (2023)

Iatrogenic Hyperinsulinemia, Not Hyperglycemia, Drives Insulin Resistance in Type 1 Diabetes as Revealed by Comparison With GCK-MODY (MODY2)
por: Gregory, Justin M., et al.
Publicado: (2019)

A single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 diabetes mellitus
por: Hohendorff, J., et al.
Publicado: (2017)

Subfractions of high-density lipoprotein (HDL) and dysfunctional HDL in chronic kidney disease patients
por: Rysz-Górzyńska, Magdalena, et al.
Publicado: (2016)

Three-year comparison of subcutaneous insulin pump treatment with multi-daily injections on HbA1c, its variability and hospital burden of children with type 1 diabetes
por: Fendler, Wojciech, et al.
Publicado: (2011)

Serum microRNA profiles in patients with autosomal dominant polycystic kidney disease show systematic dysregulation partially reversible by hemodialysis
por: Małachowska, Beata, et al.
Publicado: (2019)

Incidence of HNF1A and GCK MODY Variants in a South African Population
por: Matsha, Tandi E, et al.
Publicado: (2020)

Distinguishing the lipid profile of GCK-MODY patients and its correlation with hsCRP levels
por: Ping, Fan, et al.
Publicado: (2022)

Immune Dysregulation in Patients With Chromosome 18q Deletions—Searching for Putative Loci for Autoimmunity and Immunodeficiency
por: Hogendorf, Anna, et al.
Publicado: (2021)

Evaluation of Changes to the Oral Microbiome Based on 16S rRNA Sequencing among Children Treated for Cancer
por: Proc, Patrycja, et al.
Publicado: (2021)

Chronic Mild Hyperglycemia in GCK-MODY Patients Does Not Increase Carotid Intima-Media Thickness
por: Pruhova, Stepanka, et al.
Publicado: (2013)

Genetic and clinical characteristics of Chinese children with Glucokinase-maturity-onset diabetes of the young (GCK-MODY)
por: Li, Xiuzhen, et al.
Publicado: (2018)

Identification of GCK-MODY in cases of neonatal hyperglycemia: a case series and review of clinical features
por: Hughes, Alice E, et al.
Publicado: (2021)

GCK‐MODY in pregnancy: A pregnant woman with diabetes and a small‐for‐gestational‐age fetus
por: Yau, Tiffany Tse Ling, et al.
Publicado: (2022)

Letter to the Editor: Stress Hyperglycemia or Glucokinase Maturity Onset Diabetes of the Young (GCK-MODY) or Both?
por: Doherty-Kirby, Amanda
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dms370ihnu83toep7bmocr45su